Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Biote (BTMD) Shares Issued (2021 - 2024)

Biote has reported Shares Issued over the past 3 years, most recently at -$527000.0 for Q4 2024.

  • Quarterly results put Shares Issued at -$527000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$280000.0 (down 199.29% YoY), and the annual figure for FY2025 was $226000.0, down 19.86%.
  • Shares Issued for Q4 2024 was -$527000.0 at Biote, down from $247000.0 in the prior quarter.
  • Over the last five years, Shares Issued for BTMD hit a ceiling of $302.8 million in Q2 2021 and a floor of -$311.2 million in Q4 2021.
  • Median Shares Issued over the past 3 years was $285500.0 (2024), compared with a mean of $87750.0.
  • Peak annual rise in Shares Issued hit 22.86% in 2024, while the deepest fall reached 22.86% in 2024.
  • Biote's Shares Issued stood at -$311.2 million in 2021, then surged by 100.13% to $420000.0 in 2023, then plummeted by 225.48% to -$527000.0 in 2024.
  • The last three reported values for Shares Issued were -$527000.0 (Q4 2024), $247000.0 (Q3 2024), and $238000.0 (Q2 2024) per Business Quant data.